Novo Nordisk A/S
A Senior Research Scientist at Novo Nordisk drives early- and late-stage development of CMC injectable drug products, including peptides, proteins, and antibodies. The role involves setting scientific directions for formulation studies, ensuring product stability, and collaborating across Global Research, Regulatory Affairs, and Quality Assurance.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
40% below the average for this role
Specialist for CMC Injectable Drug Product Development
State of Indiana
Laboratory Technician, Biophysics & Injectable Formulation (one-year fixed term contract)
State of Indiana
Senior Research Scientist
State of Indiana
Open Rank Scientist-Biomolecular Technologies
State of Indiana
Sr. Associate/Consultant - Biopharma Formulations
Elanco
Senior Associate Scientist, Formulation Development (Peptide and Antibody)
Regeneron Pharmaceuticals